| Name | Bartell Drugs #27 |
|---|---|
| Organization Name | The Bartell Drug Co |
| Location | 11919 Ne 8th St, Bellevue, Washington 98005 |
| Type | Pharmacy |
| Phone | (425) 454-0146 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In the past 10 years, the global campaign to expand treatment for millions of people with AIDS living in resource-limited countries, especially in sub-Saharan Africa, has gained substantial commitments in public and private financing, and has made major strides in making treatment available to those who need it.
The investigational anti- cancer drug, phenoxodiol, considerably enhances the ability of the drug, docetaxel (Taxotere(R), Sanofi-Aventis), to kill human ovarian cancer cells in the laboratory. The findings are reported in the current issue of Oncology Research.
Witnesses at a Senate Commerce, Science and Transportation Committee hearing on Thursday discussed the need for increased consumer protections that would limit the practice of insurers underpaying for out-of-network medical services, CQ HealthBeat reports.
A trio of groundbreaking publications from researchers in Northwestern University's Physical Sciences-Oncology Center (PS-OC) report important methodological advances that will enable a better understanding of how gene expression is regulated, both in normal cells and in cancer cells. This knowledge could lead to the development of more effective therapeutic agents to treat cancer patients.
The chief executive of the American Medical Association (AMA) writes to Congress urging them to vote against the proposed amendments to the Patient Protection and Affordable Care Act (ACA). It is his belief that the MacArthur Amendment does not protect the provision of affordable healthcare to all Americans, the primary goal of the ACA.
› Verified 6 days ago
| NPI Number | 1386962298 |
| Organization Name | THE BARTELL DRUG CO |
| Doing Business As | BARTELL DRUGS #27 |
| Type | Pharmacy |
| Address | 11919 Ne 8th St, Bellevue, WA 98005 |
| Phone Number | 425-454-0146 |
News Archive
In the past 10 years, the global campaign to expand treatment for millions of people with AIDS living in resource-limited countries, especially in sub-Saharan Africa, has gained substantial commitments in public and private financing, and has made major strides in making treatment available to those who need it.
The investigational anti- cancer drug, phenoxodiol, considerably enhances the ability of the drug, docetaxel (Taxotere(R), Sanofi-Aventis), to kill human ovarian cancer cells in the laboratory. The findings are reported in the current issue of Oncology Research.
Witnesses at a Senate Commerce, Science and Transportation Committee hearing on Thursday discussed the need for increased consumer protections that would limit the practice of insurers underpaying for out-of-network medical services, CQ HealthBeat reports.
A trio of groundbreaking publications from researchers in Northwestern University's Physical Sciences-Oncology Center (PS-OC) report important methodological advances that will enable a better understanding of how gene expression is regulated, both in normal cells and in cancer cells. This knowledge could lead to the development of more effective therapeutic agents to treat cancer patients.
The chief executive of the American Medical Association (AMA) writes to Congress urging them to vote against the proposed amendments to the Patient Protection and Affordable Care Act (ACA). It is his belief that the MacArthur Amendment does not protect the provision of affordable healthcare to all Americans, the primary goal of the ACA.
› Verified 6 days ago
News Archive
In the past 10 years, the global campaign to expand treatment for millions of people with AIDS living in resource-limited countries, especially in sub-Saharan Africa, has gained substantial commitments in public and private financing, and has made major strides in making treatment available to those who need it.
The investigational anti- cancer drug, phenoxodiol, considerably enhances the ability of the drug, docetaxel (Taxotere(R), Sanofi-Aventis), to kill human ovarian cancer cells in the laboratory. The findings are reported in the current issue of Oncology Research.
Witnesses at a Senate Commerce, Science and Transportation Committee hearing on Thursday discussed the need for increased consumer protections that would limit the practice of insurers underpaying for out-of-network medical services, CQ HealthBeat reports.
A trio of groundbreaking publications from researchers in Northwestern University's Physical Sciences-Oncology Center (PS-OC) report important methodological advances that will enable a better understanding of how gene expression is regulated, both in normal cells and in cancer cells. This knowledge could lead to the development of more effective therapeutic agents to treat cancer patients.
The chief executive of the American Medical Association (AMA) writes to Congress urging them to vote against the proposed amendments to the Patient Protection and Affordable Care Act (ACA). It is his belief that the MacArthur Amendment does not protect the provision of affordable healthcare to all Americans, the primary goal of the ACA.
› Verified 6 days ago
Acute Pain Management, Pllc Type: Medicare Supplier Location: 1310 116th Ave Ne, Bellevue, Washington 98004 Phone: (425) 440-3351 | |
Center For Prosthetics Orthotics In Type: Medicare Supplier Location: 1231 116th Ave Ne, Bellevue, Washington 98004 Phone: (425) 454-4276 | |
Overlake Optical Type: Eyewear Supplier (Equipment, not the service) Location: 1300 116th Ave Ne, Bellevue, Washington 98004 Phone: (425) 454-7989 | |
Eyecare Center Llc Type: Medicare Supplier Location: 12310 Ne 8th St, Bellevue, Washington 98005 Phone: (425) 455-0001 | |
Fred Meyer Pharmacy #23 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2041 148th Neave, Bellevue, Washington 98007 Phone: (425) 865-8593 |